article thumbnail

Frost Insights: Discerning Biotech Bankruptcies in 2023

Frost & Sullivan

Biotech bankruptcies reached a record high in 2023 with over 20 companies announcing insolvency. Financial struggles in a post-COVID-19 economy and rising inflation have adversely impacted the global biotech industry. Large pharma companies need to innovate quickly to off-set emerging losses due to patent expiration.

Biotech 52
article thumbnail

Leadership in Biopharma: Key thought leaders in the Biopharma industry

Jake Jorgovan

His career highlights include igniting US reimbursement pathways for Prescription Digital Therapeutics (PDT), pioneering value-based collaboration between payers and manufacturers, and introducing groundbreaking biotech and healthtech solutions. His role involves fostering alliances within the pharmaceutical and biotech industries.

Biopharma 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top Interim & Fractional Chief Medical Officer (CMedO) Consultants, Consulting Firms, & Companies

Jake Jorgovan

TL;DR Top Interim & Fractional Chief Medical Officer (CMedO) Consultants, Consulting Firms, & Companies Biotech Exec : Provides fractional C-suite leadership to biotech and life sciences companies, offering flexible, part-time executive services to enhance growth and operational efficiency.

Biotech 130
article thumbnail

Top 12 BioPharma / Pharmaceutical Recruiters, Headhunters, and Executive Search Firms

Jake Jorgovan

And they work with anyone, from early-stage startups to established biotech and pharmaceutical companies. Real Staffing: Versatile Executive Staffing and Talent Management Real Staffing offers expert recruitment solutions tailored to the biotech and pharma sectors.

Biopharma 130
article thumbnail

The Impact of Regulatory Changes on Healthcare Business Strategies

Jake Jorgovan

Legal and ethical considerations: Evolving legal and ethical standards, such as end-of-life care, reproductive rights, and genetic testing, also drive regulatory changes in healthcare. Non-compliance can lead to legal penalties and damage to reputation, while effective compliance can enhance the organization’s standing.

Legal 130
article thumbnail

Hello from the other side: CSL

Stellar Partnerships

CSL is a global biotech company and one of Australia’s biggest success stories, with profits of over $2.2bln last year. Over the next 12 months we try to support them from a volunteering perspective, such as pro-bono legal support from our Australian based legal operations.

Biotech 130
article thumbnail

Balancing Act in Health and Science, IR & Communications

LaVoie Health Science Blog

All biotech companies require substantial capital to fund product development and are subject to Food and Drug Administration (FDA) regulations. This can be tricky and often requires involvement of legal counsel and executive management. A survey of CCOs from different sectors would demonstrate many similarities in the function.

Biotech 52